Hepatitis B Vaccine (Recombinant) Adjuvanted

FDA Drug Profile — HEPLISAV-B

Hepatitis B Vaccine (Recombinant) Adjuvanted is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including HEPLISAV-B. Available dosage form: injection, solution.

Drug Details

Generic Name
Hepatitis B Vaccine (Recombinant) Adjuvanted
Brand Names
HEPLISAV-B
Application Number
BLA125428
Sponsor
A-S Medication Solutions
NDC Codes
3
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients
HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN